Results 221 to 230 of about 239,193 (267)
Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes. [PDF]
Zhou D+17 more
europepmc +1 more source
Abstract Objective Dravet syndrome is a developmental and epileptic encephalopathy characterized by drug‐resistance, lifelong seizures, and significant comorbidities including intellectual and motor impairment. Receiving a diagnosis of Dravet syndrome is challenging for parents/caregivers, and little research has focused on how the diagnosis should be ...
Andreas Brunklaus+9 more
wiley +1 more source
Primary diagnosis of atrioventricular pseudo-block in a neonate with definitive diagnosis of long QT syndrome: diagnostic considerations and therapeutic approaches. [PDF]
Khorgami M, Naderi F, Kalayinia S.
europepmc +1 more source
Abstract The Ankyrin 2 (ANK2) gene encodes the ankyrin‐B protein (ANKB), which is involved in the organization and stability of membrane ion channels, transporters, and receptors in cardiomyocytes and neurons. Variants in ANK2 genes are initially reported in long QT syndrome and autism.
Po‐Hsi Lin+5 more
wiley +1 more source
Heart on Fire: Unmasking <i>RyR2</i> Mutation in Stress-Induced Ventricular Arrhythmias. [PDF]
Sharma V+5 more
europepmc +1 more source
Statins' protective effects on focal epilepsy are independent of LDL‐C
Abstract Objective This study evaluates the potential protective effects of statins against epilepsy, focusing on their differential impacts on focal and generalized epilepsy. It investigates the role of statins through the HMGCR gene and associated low‐density lipoprotein (LDL) cholesterol levels.
Zhen Sun+6 more
wiley +1 more source
Sex Differences in the Incidence of Sudden Cardiac Arrest/Death in Competitive Athletes: A Systematic Review and Meta-analysis. [PDF]
Li L+3 more
europepmc +1 more source
Abstract Objective To report interim data from an ongoing, open‐label extension (OLE) of a Phase 2b study (X‐TOLE) of azetukalner in adults with focal onset seizures (FOS) receiving 1–3 antiseizure medications. Methods Eligible participants enrolled in the 7‐year OLE at 20 mg azetukalner once daily with food.
Jacqueline A. French+62 more
wiley +1 more source
Sudden Cardiac Arrest Among Young Competitive Athletes Before and During the COVID-19 Pandemic.
Astley C+6 more
europepmc +1 more source